COFEPRIS regulates the transfer of rights to ensure legal and technical compliance for medicines, medical devices, and biological products. Requirements include an application format, proof of payment, legal documentation, and a notice of operation. Transfers must be transparent, with continuous monitoring. Modifications now resolve within 24 hours instead of 3 months.
The transfer of rights in the regulatory context is essential to ensure continuity and legality in the management of rights and obligations related to regulated products, such as medicines, medical devices and biological products, among others.
COFEPRIS, Mexico's medical device regulator, dictates this process with the objective of guaranteeing that any transfer of rights is carried out in a transparent manner, ensuring that the new owners comply with the legal and technical requirements necessary for the proper operation and marketing of products under their responsibility. This includes evaluation of relevant documentation, verification of the transferee's suitability, and ongoing monitoring to ensure compliance with applicable COFEPRIS regulations.
The requirements for the transfer of rights to medical devices are:
Apart from the indicated requirements, the following must be considered:
The steps to follow to submit the procedures for immediate resolution modifications are:
This guide was published on June 25th 2024 and it starts operation until July 8, 2024, according to COFEPRIS web page.
Learn more about COFEPRIS Mexico Medical Device Registration.
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us